A novel magnetically controlled bioreactor for ex vivo expansion of NK-92 cells

Abstract

The application of natural killer (NK) cells as potential antitumor effector cells appears to be valuable for immunotherapies. However, the clinical use of NK cells is limited because the technical difficulties associated with mass production NK cells at sufficiently high numbers represents a great challenge. Ex vivo expansion of NK cells is a key technology for cell therapy. Bioreactor systems can generate homogeneous culture condition and modulate the environmental and biochemical cues. In this study, a novel magnetically controlled bioreactor was developed for supporting NK cells ex vivo expansion. Using synthetic magnetic beads, the stirring device of the magnetically controlled bioreactor generated reduced shearing force. The intermittent magnetic field was applied for magnetic beads movement to homogenize the culture system. NK-92 cells were cultured in the magnetically controlled bioreactor and the expansion and function of expanded cells were investigated on day 8. The results showed that the expansion of NK-92 cells in the bioreactor was 67.71 ± 10.60-fold, which was significantly higher than that of the T25 culture flask (P < 0.05). Moreover, the proportions of CD3⁻CD56⁺ cells and cell killing activity of expanded cells in the bioreactor did not reveal any differences compared to T25 flasks. Taken together, this study demonstrated the possibility of magnetically controlled bioreactor as a potent strategy in NK cells production for facilitating cancer immunotherapy.

Keywords

NK-92 cells / Bioreactor / Magnetic field / Ex vivo expansion

References

[1] Badenes SM, Fernandes TG, Rodrigues CAV. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems. J Biotechnol, 2016, 234: 71-82.

[2] Bröker K, Sinelnikov E, Gustavus D. Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor. Front Bioeng Biotechnol, 2019, 7: 194.

[3] Canseven AG, Seyhan N, Mirshahidi S. Suppression of natural killer cell activity on Candida stellatoidea by a 50 Hz magnetic field. Electromagn Biol Med, 2006, 25: 79-85.

[4] Collignon M-L, Delafosse A, Crine M. Axial impeller selection for anchorage dependent animal cell culture in stirred bioreactors: Methodology based on the impeller comparison at just-suspended speed of rotation. Chem Eng Sci, 2010, 65: 5929-5941.

[5] Curcio E, Piscioneri A, Salerno S. Human lymphocytes cultured in 3-D bioreactors: influence of configuration on metabolite transport and reactions. Biomaterials, 2012, 33: 8296-8303.

[6] De Seze R, Bouthet C, Tuffet S. Effects of time-varying uniform magnetic fields on natural killer cell activity and antibody response in mice. Bioelectromagnetics, 1993, 14: 405-412.

[7] Dini L, Abbro L. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron, 2005, 36: 195-217.

[8] Gobba F, Bargellini A, Scaringi M. Extremely low frequency-magnetic fields (ELF-EMF) occupational exposure and natural killer activity in peripheral blood lymphocytes. Sci Total Environ, 2009, 407: 1218-1223.

[9] Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia, 1994, 8: 652-658.

[10] Hosseinizand H, Ebrahimi M, Abdekhodaie MJ. Agitation increases expansion of cord blood hematopoietic cells and promotes their differentiation into myeloid lineage. Cytotechnology, 2016, 68: 969-978.

[11] House RV, Mccormick DL. Modulation of natural killer cell function after exposure to 60 Hz magnetic fields: confirmation of the effect in mature B6C3F (1) mice. Radiat Res, 2000, 153: 722-724.

[12] Kaiser AD, Assenmacher M, Schroder B. Towards a commercial process for the manufacture of genetically modified t cells for therapy. Cancer Gene Ther, 2015, 22: 72-78.

[13] Klingemann H, Boissel L, Toneguzzo F. Natural killer cells for immunotherapy—advantages of the NK-92 cell line over blood NK cells. Front Immunol, 2016, 7: 91.

[14] Lin SL, Su YT, Feng SW, . Enhancement of natural killer cell cytotoxicity by using static magnetic field to increase their viability. Electromagn Biol Med, 2019, 38: 131-142.

[15] Liu Y, Liu T, Fan X. Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel. J Biotechnol, 2006, 124: 592-601.

[16] Ljunggren HG, Kärre KJIT. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today, 1990, 11: 237-244.

[17] Luetke-Eversloh M, Killig M, Romagnani C. Signatures of human NK cell development and terminal differentiation. Front Immunol, 2013, 4: 499.

[18] Mckee C, Chaudhry GR. Advances and challenges in stem cell culture. Colloids Surf B Biointerfaces, 2017, 159: 62-77.

[19] Meng Y, Sun J, Hu T. Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy. Hum Vaccin Immunother, 2018, 14: 2516-2526.

[20] Miyakoshi J. Effects of static magnetic fields at the cellular level. Prog Biophys Mol Biol, 2005, 87: 213-223.

[21] Onodera H, Jin Z, Chida S. Effects of 10-T static magnetic field on human peripheral blood immune cells. Radiat Res, 2003, 159: 775-779.

[22] Ou J, Si Y, Tang Y. Novel biomanufacturing platform for large-scale and high-quality human T cells production. J Biol Eng, 2019, 13: 34.

[23] Rodling L, Volz EM, Raic A. Magnetic macroporous hydrogels as a novel approach for perfused stem cell culture in 3D scaffolds via contactless motion control. Adv Healthc Mater, 2018, 7: e1701403.

[24] Rodrigues CA, Fernandes TG, Diogo MM. Stem cell cultivation in bioreactors. Biotechnol Adv, 2011, 29: 815-829.

[25] Sadeghi A, Pauler L, Annerén C. Large-scale bioreactor expansion of tumor-infiltrating lymphocytes. J Immunol Methods, 2011, 364: 94-100.

[26] Suck G, Odendahl M, Nowakowska P. NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy. Cancer Immunol Immunother, 2016, 65: 485-492.

[27] Sutlu T, Stellan B, Gilljam M. Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor. Cytotherapy, 2010, 12: 1044-1055.

[28] Verheyden S, Demanet C. NK cell receptors and their ligands in leukemia. Leukemia, 2008, 22: 249-257.

[29] Wang Z, Guo L, Song Y. Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-betaR II and NKG2D. Cancer Immunol Immunother, 2017, 66: 537-548.

[30] Zhang L, Ji XM, Yang XX. Cell type- and density-dependent effect of 1 T static magnetic field on cell proliferation. Oncotarget, 2017, 8: 13126-13141.

[31] Zhang W, Cai H, Tan W-S. Dynamic suspension culture improves ex vivo expansion of cytokine-induced killer cells by upregulating cell activation and glucose consumption rate. J Biotechnol, 2018, 287: 8-17.

[32] Zhang J, Zheng H, Diao Y. Natural killer cells and current applications of chimeric antigen receptor-modified NK-92 cells in tumor immunotherapy. Int J Mol Sci, 2019, 20: 317.